Skip to main content
Top
Published in: Cough 1/2005

Open Access 01-12-2005 | Research

No effect of omeprazole on pH of exhaled breath condensate in cough associated with gastro-oesophageal reflux

Authors: Alfonso Torrego, Stefan Cimbollek, Mark Hew, Kian Fan Chung

Published in: Cough | Issue 1/2005

Login to get access

Abstract

Background

Endogenous airway acidification evaluated as pH in exhaled breath condensate (EBC) has been described in patients with chronic cough. Proton pump inhibitors improve gastro-oesophageal reflux (GOR)-associated cough.

Methods

We examined pH levels in EBC and capsaicin cough response in 13 patients with chronic cough (mean age 41 years, SD 9) associated with GOR before and after omeprazole treatment (40 mg/day for 14 days) and its relationship with clinical response.

Results

Omeprazole abolished symptoms associated with GOR. Patients with chronic cough had an EBC pH of 8.28 (SD 0.13) prior to treatment but this did not change with omeprazole treatment. There was a significant improvement in the Leicester Cough Questionnaire symptom scores from 80.8 points (SD 13.2) to 95.1 (SD 17) (p = 0.02) and in a 6-point scale of cough scores, but there was no change in capsaicin cough response.

Conclusion

An improvement in GOR-associated cough was not associated with changes in EBC pH or capsaicin cough response. These parameters are not useful markers of therapeutic response.
Appendix
Available only for authorised users
Literature
1.
go back to reference Irwin RS, Curley FJ, French CL: Chronic cough: the spectrum and frequency of causes, key components of the diagnostic evaluation, and outcome of specific therapy. Amer Rev Respir Dis. 1990, 141: 640-7.CrossRef Irwin RS, Curley FJ, French CL: Chronic cough: the spectrum and frequency of causes, key components of the diagnostic evaluation, and outcome of specific therapy. Amer Rev Respir Dis. 1990, 141: 640-7.CrossRef
3.
go back to reference Poe RH, Kallay MC: Chronic cough and gastroesophageal reflux disease: experience with specific therapy for diagnosis and treatment. Chest. 2003, 123: 679-84. 10.1378/chest.123.3.679.CrossRefPubMed Poe RH, Kallay MC: Chronic cough and gastroesophageal reflux disease: experience with specific therapy for diagnosis and treatment. Chest. 2003, 123: 679-84. 10.1378/chest.123.3.679.CrossRefPubMed
4.
go back to reference Ing AJ, Ngu MC: Cough and gastro-oesophageal reflux. Lancet. 1999, 353: 944-6. 10.1016/S0140-6736(98)00354-7.CrossRefPubMed Ing AJ, Ngu MC: Cough and gastro-oesophageal reflux. Lancet. 1999, 353: 944-6. 10.1016/S0140-6736(98)00354-7.CrossRefPubMed
5.
go back to reference Ours TM, Kavuru MS, Schilz RJ, Richter JE: A prospective evaluation of esophageal testing and a double-blind, randomized study of omeprazole in a diagnostic and therapeutic algorithm for chronic cough. Am J Gastroenterol. 1999, 94: 3131-8. 10.1111/j.1572-0241.1999.01504.x.CrossRefPubMed Ours TM, Kavuru MS, Schilz RJ, Richter JE: A prospective evaluation of esophageal testing and a double-blind, randomized study of omeprazole in a diagnostic and therapeutic algorithm for chronic cough. Am J Gastroenterol. 1999, 94: 3131-8. 10.1111/j.1572-0241.1999.01504.x.CrossRefPubMed
6.
go back to reference Kiljander TO, Salomaa ER, Hietanen EK, Terho EO: Chronic cough and gastro-oesophageal reflux: a double-blind placebo-controlled study with omeprazole. Eur Respir J. 2000, 16: 633-8. 10.1034/j.1399-3003.2000.16d11.x.CrossRefPubMed Kiljander TO, Salomaa ER, Hietanen EK, Terho EO: Chronic cough and gastro-oesophageal reflux: a double-blind placebo-controlled study with omeprazole. Eur Respir J. 2000, 16: 633-8. 10.1034/j.1399-3003.2000.16d11.x.CrossRefPubMed
7.
go back to reference Kollarik M, Undem BJ: Mechanisms of acid-induced activation of airway afferent nerve fibres in guinea-pig. J Physiol. 2002, 543: 591-600. 10.1113/jphysiol.2002.022848.PubMedCentralCrossRefPubMed Kollarik M, Undem BJ: Mechanisms of acid-induced activation of airway afferent nerve fibres in guinea-pig. J Physiol. 2002, 543: 591-600. 10.1113/jphysiol.2002.022848.PubMedCentralCrossRefPubMed
8.
go back to reference Niimi A, Nguyen LT, Usmani O, Mann B, Chung KF: Reduced pH and chloride levels in exhaled breath condensate of patients with chronic cough. Thorax. 2004, 59: 608-12. 10.1136/thx.2003.012906.PubMedCentralCrossRefPubMed Niimi A, Nguyen LT, Usmani O, Mann B, Chung KF: Reduced pH and chloride levels in exhaled breath condensate of patients with chronic cough. Thorax. 2004, 59: 608-12. 10.1136/thx.2003.012906.PubMedCentralCrossRefPubMed
9.
go back to reference Fox AJ, Urban L, Barnes PJ, Dray A: Effects of casazepine against capsaicin- and proton-evoked excitation of single airway c-fibres and vagus nerve from the guinea-pig. Neurosci Lett. 1995, 15: 421-28. Fox AJ, Urban L, Barnes PJ, Dray A: Effects of casazepine against capsaicin- and proton-evoked excitation of single airway c-fibres and vagus nerve from the guinea-pig. Neurosci Lett. 1995, 15: 421-28.
10.
go back to reference Birring SS, Prudon B, Carr AJ, Singh SJ, Morgan MD, Pavord ID: Development of a symptom specific health status measure for patients with chronic cough: Leicester Cough Questionnaire (LCQ). Thorax. 2003, 58: 339-43. 10.1136/thorax.58.4.339.PubMedCentralCrossRefPubMed Birring SS, Prudon B, Carr AJ, Singh SJ, Morgan MD, Pavord ID: Development of a symptom specific health status measure for patients with chronic cough: Leicester Cough Questionnaire (LCQ). Thorax. 2003, 58: 339-43. 10.1136/thorax.58.4.339.PubMedCentralCrossRefPubMed
11.
go back to reference Hsu JY, Stone RA, Logan Sinclair RB, Worsdell M, Busst CM, Chung KF: Coughing frequency in patients with persistent cough: assessment using a 24 hour ambulatory recorder. Eur Respir J. 1994, 7: 1246-53. 10.1183/09031936.94.07071246.CrossRefPubMed Hsu JY, Stone RA, Logan Sinclair RB, Worsdell M, Busst CM, Chung KF: Coughing frequency in patients with persistent cough: assessment using a 24 hour ambulatory recorder. Eur Respir J. 1994, 7: 1246-53. 10.1183/09031936.94.07071246.CrossRefPubMed
12.
go back to reference Lalloo UG, Fox AJ, Belvisi MB, Chung KF, Barnes PJ: Capsazepine inhibits cough induced by capsaicin and citric acid but not by hypertonic saline in guinea pigs. J Appl Physiol. 1995, 79: 1082-7.PubMed Lalloo UG, Fox AJ, Belvisi MB, Chung KF, Barnes PJ: Capsazepine inhibits cough induced by capsaicin and citric acid but not by hypertonic saline in guinea pigs. J Appl Physiol. 1995, 79: 1082-7.PubMed
13.
go back to reference Vaughan J, Ngamtrakulpanit L, Pajewski TN, Turner R, Nguyen TA, Smith A, Urban P, Hom S, Gaston B, Hunt J: Exhaled breath condensate pH is a robust and reproducible assay of airway acidity. Eur Respir J. 2003, 22: 889-94.CrossRefPubMed Vaughan J, Ngamtrakulpanit L, Pajewski TN, Turner R, Nguyen TA, Smith A, Urban P, Hom S, Gaston B, Hunt J: Exhaled breath condensate pH is a robust and reproducible assay of airway acidity. Eur Respir J. 2003, 22: 889-94.CrossRefPubMed
14.
go back to reference Kostikas K, Papatheodorou G, Ganas K, Psathakis K, Panagou P, Loukides S: pH in expired breath condensate of patients with inflammatory airway diseases. Am J Respir Crit Care Med. 2002, 15: 1364-70. 10.1164/rccm.200111-068OC.CrossRef Kostikas K, Papatheodorou G, Ganas K, Psathakis K, Panagou P, Loukides S: pH in expired breath condensate of patients with inflammatory airway diseases. Am J Respir Crit Care Med. 2002, 15: 1364-70. 10.1164/rccm.200111-068OC.CrossRef
15.
go back to reference Jack CI, Calverley PM, Donnelly RJ, Tran J, Russell G, Hind CR, Evans CC: Simultaneous tracheal and oesophageal pH measurements in asthmatic patients with gastroesophageal reflux. Thorax. 1995, 50: 201-4.PubMedCentralCrossRefPubMed Jack CI, Calverley PM, Donnelly RJ, Tran J, Russell G, Hind CR, Evans CC: Simultaneous tracheal and oesophageal pH measurements in asthmatic patients with gastroesophageal reflux. Thorax. 1995, 50: 201-4.PubMedCentralCrossRefPubMed
16.
go back to reference Yorulmaz I, Ozlugedik S, Kucuk B: Gastroesophageal reflux disease: symptoms versus pH monitoring results. Otolaryngol Head Neck Surg. 2003, 129: 582-6. 10.1016/S0194-5998(03)01585-7.CrossRefPubMed Yorulmaz I, Ozlugedik S, Kucuk B: Gastroesophageal reflux disease: symptoms versus pH monitoring results. Otolaryngol Head Neck Surg. 2003, 129: 582-6. 10.1016/S0194-5998(03)01585-7.CrossRefPubMed
17.
go back to reference Benini L, Ferrari M, Sembenini C, Olivieri M, Micciolo R, Zuccali V, Bulighin GM, Fiorino F, Ederle A, Cascio VL, Vantini I: Cough threshold in reflux oesophagitis: influence of acid and of laryngeal and oesophageal damage. Gut. 2000, 46: 762-7. 10.1136/gut.46.6.762.PubMedCentralCrossRefPubMed Benini L, Ferrari M, Sembenini C, Olivieri M, Micciolo R, Zuccali V, Bulighin GM, Fiorino F, Ederle A, Cascio VL, Vantini I: Cough threshold in reflux oesophagitis: influence of acid and of laryngeal and oesophageal damage. Gut. 2000, 46: 762-7. 10.1136/gut.46.6.762.PubMedCentralCrossRefPubMed
18.
go back to reference Nieto L, de Diego A, Perpina M, Compte L, Garrigues V, Martinez E, Ponce J: Cough reflex testing with inhaled capsaicin in the study of chronic cough. Respir Med. 2003, 97: 393-400. 10.1053/rmed.2002.1460.CrossRefPubMed Nieto L, de Diego A, Perpina M, Compte L, Garrigues V, Martinez E, Ponce J: Cough reflex testing with inhaled capsaicin in the study of chronic cough. Respir Med. 2003, 97: 393-400. 10.1053/rmed.2002.1460.CrossRefPubMed
Metadata
Title
No effect of omeprazole on pH of exhaled breath condensate in cough associated with gastro-oesophageal reflux
Authors
Alfonso Torrego
Stefan Cimbollek
Mark Hew
Kian Fan Chung
Publication date
01-12-2005
Publisher
BioMed Central
Published in
Cough / Issue 1/2005
Electronic ISSN: 1745-9974
DOI
https://doi.org/10.1186/1745-9974-1-10

Other articles of this Issue 1/2005

Cough 1/2005 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.